Cleared Traditional

K111007 - MIDWEST REPROCESSING CENTER REPROCESSED LNCS SESSORS (FDA 510(k) Clearance)

Also includes:
MIDWEST REPROCESSING CENTER REPROCESSED OXIMAX SENSORS MIDWEST RE

Class II Cardiovascular device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K111007 · Midwest Reprocessing Center, LLC · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2011
Decision
58d
Days
Class 2
Risk

K111007 is an FDA 510(k) clearance for the MIDWEST REPROCESSING CENTER REPROCESSED LNCS SESSORS. Classified as Oximeter, Tissue Saturation, Reprocessed (product code NMD), Class II - Special Controls.

Submitted by Midwest Reprocessing Center, LLC (Birmingham, US). The FDA issued a Cleared decision on June 8, 2011 after a review of 58 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2700 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Midwest Reprocessing Center, LLC devices

Submission Details

510(k) Number K111007 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 11, 2011
Decision Date June 08, 2011
Days to Decision 58 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
67d faster than avg
Panel avg: 125d · This submission: 58d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code NMD Oximeter, Tissue Saturation, Reprocessed
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2700
Definition Reprocessing Validation Data For This Device Type Must Be Included In A 510(k) Submission. (70 Fr 56911, Available At Https://www.govinfo.gov/content/pkg/fr-2005-09-29/pdf/05-19510.pdf).
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.